Elanco has updated its Component line of cattle implants to comply with new CVM regulations. To help ease this transition, Elanco is outlining the changes to its cattle implant portfolio with producers, veterinarians and nutritionists.
Effective December 22, 2023, Elanco’s Component with Tylan implants will now require a prescription from a veterinarian. This includes:
• Component E-C with Tylan (progesterone and estradiol benzoate and tylosin tartrate implants)
• Component TE-G with Tylan (trenbolone acetate, estradiol and tylosin tartrate implants)
• Component TE-IH with Tylan (trenbolone acetate, estradiol and tylosin tartrate implants)
• Component TE-IS with Tylan (trenbolone acetate, estradiol and tylosin tartrate implants)
• Component TE-200 with Tylan (trenbolone acetate, estradiol and tylosin tartrate implants)
On January 2, 2024, Elanco will offer the following implants without the Tylan pellet, giving producers flexibility for an over-the-counter (OTC) purchase for their implant program:
• Component E-C
• Component TE-G
Elanco will be replacing the current oxytetracycline coating with a sodium bicarbonate coating for two of its implant brands, allowing them to remain OTC. New product will be available in March 2024 for:
• Compudose
• Encore
The following Elanco implants have been discontinued:
• Component E-H with Tylan
• Component E-S with Tylan
• Component TE-H with Tylan
• Component TE-S with Tylan
Despite the changes to the marketplace under Guidance for Industry (GFI) #191 and #263, Elanco remains committed to healthy animals and providing value through solutions that help producers manage animal performance to meet market needs.
